Kevin Caliendo
Stock Analyst at UBS
(4.17)
# 444
Out of 4,935 analysts
193
Total ratings
65.56%
Success rate
8.91%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XRAY DENTSPLY SIRONA | Maintains: Buy | $25 → $24 | $13.00 | +84.62% | 11 | Aug 8, 2025 | |
| LFST LifeStance Health Group | Maintains: Buy | $8.5 → $9 | $4.31 | +108.82% | 5 | Aug 8, 2025 | |
| HSIC Henry Schein | Maintains: Neutral | $75 → $70 | $65.85 | +6.30% | 6 | Aug 6, 2025 | |
| NVST Envista Holdings | Maintains: Neutral | $18 → $22 | $20.23 | +8.75% | 4 | Jul 29, 2025 | |
| MOH Molina Healthcare | Maintains: Neutral | $260 → $180 | $157.79 | +14.08% | 4 | Jul 25, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $282 → $305 | $266.29 | +14.54% | 4 | Jul 25, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $175 → $180 | $176.52 | +1.97% | 15 | Jul 23, 2025 | |
| CVS CVS Health | Maintains: Neutral | $71 → $67 | $65.40 | +2.45% | 8 | Jul 22, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $400 → $385 | $249.36 | +54.40% | 12 | Jun 25, 2025 | |
| ZIMV ZimVie | Maintains: Neutral | $16 → $10 | $18.84 | -46.92% | 1 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6 → $5.25 | $3.48 | +50.86% | 4 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $8.93 | +67.97% | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $7.17 | +25.52% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $17 | $14.41 | +18.01% | 7 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $170 | $157.14 | +8.18% | 17 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $708 → $805 | $666.52 | +20.78% | 14 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $298 → $335 | $284.97 | +17.56% | 2 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $240 → $215 | $139.39 | +54.24% | 18 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $13 | $6.85 | +89.78% | 5 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $274.93 | +41.85% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $11.92 | -16.07% | 14 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $265.08 | -5.69% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $25.59 | +208.77% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $26 | $23.13 | +12.43% | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $293.95 | +95.61% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $173.63 | +3.67% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $6.96 | +935.23% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $16.34 | -32.68% | 4 | May 4, 2021 |
DENTSPLY SIRONA
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $24
Current: $13.00
Upside: +84.62%
LifeStance Health Group
Aug 8, 2025
Maintains: Buy
Price Target: $8.5 → $9
Current: $4.31
Upside: +108.82%
Henry Schein
Aug 6, 2025
Maintains: Neutral
Price Target: $75 → $70
Current: $65.85
Upside: +6.30%
Envista Holdings
Jul 29, 2025
Maintains: Neutral
Price Target: $18 → $22
Current: $20.23
Upside: +8.75%
Molina Healthcare
Jul 25, 2025
Maintains: Neutral
Price Target: $260 → $180
Current: $157.79
Upside: +14.08%
Labcorp Holdings
Jul 25, 2025
Maintains: Buy
Price Target: $282 → $305
Current: $266.29
Upside: +14.54%
Quest Diagnostics
Jul 23, 2025
Maintains: Neutral
Price Target: $175 → $180
Current: $176.52
Upside: +1.97%
CVS Health
Jul 22, 2025
Maintains: Neutral
Price Target: $71 → $67
Current: $65.40
Upside: +2.45%
UnitedHealth Group
Jun 25, 2025
Maintains: Buy
Price Target: $400 → $385
Current: $249.36
Upside: +54.40%
ZimVie
May 15, 2025
Maintains: Neutral
Price Target: $16 → $10
Current: $18.84
Upside: -46.92%
May 13, 2025
Maintains: Neutral
Price Target: $6 → $5.25
Current: $3.48
Upside: +50.86%
May 9, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $8.93
Upside: +67.97%
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $7.17
Upside: +25.52%
May 2, 2025
Maintains: Neutral
Price Target: $16 → $17
Current: $14.41
Upside: +18.01%
May 2, 2025
Maintains: Buy
Price Target: $160 → $170
Current: $157.14
Upside: +8.18%
Apr 29, 2025
Maintains: Buy
Price Target: $708 → $805
Current: $666.52
Upside: +20.78%
Apr 29, 2025
Maintains: Buy
Price Target: $298 → $335
Current: $284.97
Upside: +17.56%
Apr 24, 2025
Maintains: Neutral
Price Target: $240 → $215
Current: $139.39
Upside: +54.24%
Feb 13, 2025
Maintains: Buy
Price Target: $25 → $13
Current: $6.85
Upside: +89.78%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $274.93
Upside: +41.85%
Oct 17, 2024
Maintains: Neutral
Price Target: $9 → $10
Current: $11.92
Upside: -16.07%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $265.08
Upside: -5.69%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $25.59
Upside: +208.77%
Aug 23, 2023
Maintains: Neutral
Price Target: $29 → $26
Current: $23.13
Upside: +12.43%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $293.95
Upside: +95.61%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $173.63
Upside: +3.67%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $6.96
Upside: +935.23%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $16.34
Upside: -32.68%